<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000044821"><TermName>endothelin receptor antagonist</TermName><TermPronunciation>(EN-doh-THEE-lin reh-SEP-ter an-TA-guh-nist)</TermPronunciation><TermDefinition><DefinitionText>A drug that blocks the hormone endothelin and may prevent prostate cancer from spreading to the bones. It may also prevent the growth and spread of other types of cancer, including colorectal cancer.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000706024" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;endothelin receptor antagonist&quot;" language="en" id="_3"/><MediaLink ref="CDR0000706023" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;antagonista del receptor de endotelina&quot;" language="es" id="_4"/><SpanishTermName>antagonista del receptor de endotelina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que bloquea la hormona endotelina y podría prevenir que el cáncer de próstata se disemine hacia los huesos. También podría prevenir el crecimiento y la diseminación de otros tipos de cáncer, como el cáncer colorrectal.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2008-01-14</DateLastModified></GlossaryTerm>
